Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Dr Daniel Puleston has been awarded a four year Sir Henry Wellcome Postdoctoral Fellowship. The fellowship is designed to help promising early stage researchers launch an independent research career, and will support Daniel as he investigates the link between cellular metabolism and immunity.

Daniel will work with Prof Erika Pearce at the Max Planck Institute for Immunology, Germany, to examine how specific cellular metabolites support T cells in their ability to rapidly multiply in response to pathogens. Ultimately, Daniel hopes his studies will reveal vital signalling pathways that can be targeted to manipulate the immune response in diseases such as autoimmunity and cancer.

The project will also involve close collaboration with Kennedy investigators Prof Katja Simon and Prof Fiona Powrie, as well as Dr Alfredo Castello (Oxford) and Prof Doreen Cantrell (Dundee).

Speaking of his fellowship, Daniel said “I am incredibly grateful to receive a Sir Henry Wellcome Fellowship from the Wellcome Trust. This fellowship is unique in that it allows me to carry out my postdoctoral work at two world-class centres, the Kennedy Institute at Oxford and the Max Planck Institute for Immunology in Freiburg. The research performed in both locations will hopefully expand our knowledge on the role cellular metabolism plays in the immune response and how metabolic pathways can be targeted to modulate the immune system."

Daniel recently completed his DPhil with Prof Katja Simon. His work showed a cellular ‘cleanup’ process called autophagy is needed to establish long-term immunity after vaccination. He also found drugs that boost autophagy overcome the weak responses to vaccination that are associated with ageing.

Similar stories

MRC funding awarded to Kennedy researchers

Two new projects led by Tal Arnon and Irina Udalova have been awarded Medical Research Council (MRC) funding.

Kennedy researchers awarded funding to improve the understanding of inflammatory bowel diseases

A new £1.5M grant from the Medical Research Council (MRC) to the Powrie Group at the Kennedy Institute will help define different pathotypes of inflammatory bowel diseases that could lead to better and more focused treatments for patients.

Wellcome Trust Investigator Award for Professor Arnon

Congratulations to Professor Arnon on her successful Wellcome Trust Investigator Award entitled: “Spatiotemporal basis of adaptive immunity in the spleen.”

Oxford researchers awarded funding to study the immune response to malaria

Professors Matthew Higgins and Michael Dustin from the University of Oxford, Prof Gavin Wright from the University of York, and Professors Shiroh Iwanaga and Hisashi Arase from Osaka University have secured a Wellcome Collaborative Award for their study “How do RIFINs and STEVORs modulate human immunity during malaria?”

New funding awarded to study persistent pain in inflammatory arthritis

The £3.9M Wellcome Collaborative Award will be used to identify the drivers of pain in people living with rheumatoid arthritis.

Single-cell ancestry vaccine research funded by the Chan Zuckerberg Initiative

The Chan Zuckerberg Initiative (CZI) has provided $2 million in funding to investigate how our ancestry and diversity influence the way that vaccines work in our cells.